Alnylam Pharmaceuticals, Inc. (FRA:DUL)
340.10
-2.60 (-0.76%)
At close: Jan 9, 2026
Alnylam Pharmaceuticals Market Cap
Alnylam Pharmaceuticals has a market cap or net worth of €45.24 billion as of January 9, 2026. Its market cap has increased by 50.52% in one year.
Market Cap
45.24B
Enterprise Value
45.28B
Revenue
2.74B
Ranking
n/a
PE Ratio
1,218.33
Stock Price
€340.10
Market Cap Chart
Since May 28, 2004, Alnylam Pharmaceuticals's market cap has increased from 94.86M to 45.24B, an increase of 47,589.12%. That is a compound annual growth rate of 32.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 45.24B | 1.10% |
| Dec 31, 2025 | 44.74B | 52.63% |
| Dec 31, 2024 | 29.32B | 34.90% |
| Dec 29, 2023 | 21.73B | -20.57% |
| Dec 30, 2022 | 27.36B | 53.40% |
| Dec 31, 2021 | 17.83B | 44.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SAP SE | 247.30B |
| Siemens Aktiengesellschaft | 197.59B |
| Allianz SE | 145.37B |
| Deutsche Telekom AG | 134.99B |
| Siemens Energy AG | 107.65B |
| Rheinmetall AG | 87.17B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 67.47B |
| Deutsche Bank Aktiengesellschaft | 63.02B |